As clinical drug development becomes more complex and resource-intensive, the FDA’s recent draft guidance on the use of Bayesian statistical methods in clinical trials signals a move toward more ...
Bayesian spatial survival modelling combines probabilistic time-to-event analysis with spatial correlation structures to improve inference on how risk varies across locations. At its core, the ...